首页 | 本学科首页   官方微博 | 高级检索  
     

香草酸受体激动剂的研究进展
引用本文:张晓燕,张惠斌,黄文龙. 香草酸受体激动剂的研究进展[J]. 中国新药杂志, 2006, 15(23): 2006-2009
作者姓名:张晓燕  张惠斌  黄文龙
作者单位:1. 中国药科大学药物化学专业,南京,210009
2. 中国药科大学新药研究中心,南京,210009
摘    要:疼痛是很多疾病的常见症状,香草酸受体激动剂为治疗疼痛提供了一个新方向,部分药物已经进入临床研究阶段。现简单介绍了香草酸受体亚型1的结构及组织分布,并总结了近年来部分香草酸受体激动剂的研究状况。因为香草酸受体激动剂激动受体会产生一定的不良反应,因此目前用香草酸受体阻滞剂来治疗疼痛也开始受到关注。

关 键 词:疼痛  香草酸受体  激动剂
文章编号:1003-3734(2006)23-2006-04
收稿时间:2006-07-10
修稿时间:2006-07-10

Recent development of vanilloid receptor 1 agonists
ZHANG Xiao-yan,ZHANG Hui-bin,HUANG Wen-long. Recent development of vanilloid receptor 1 agonists[J]. Chinese Journal of New Drugs, 2006, 15(23): 2006-2009
Authors:ZHANG Xiao-yan  ZHANG Hui-bin  HUANG Wen-long
Affiliation:1. Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, China ; 2 Center of Drug Discovery, China Pharmaceutical University, Nanjing 210009, China
Abstract:Pain is the common syndrome of many diseases. Vanilloid receptor 1 (VR1),a ligand -gated ion channel activated by vanilloids, acid, and heat, is a molecular detector that integrates multiple modes of pain. Some of VR1 agonists have been used as the therapeutic agents in the clinical trial settings. This review briefly introduces the structure and distribution of VR1 as well as recent progresses of VR1 agonists in passing years. Currently, attentions have been paid to VR1 antagonists for the pain relief because of the more incidence of side effects developed by VR1 agonists.
Keywords:pain  vanilloid receptor 1   agonist
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国新药杂志》浏览原始摘要信息
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号